NEWS COMMENTARY

FDA authorizes emergency use of Lucira's at-home test kit – with results in 30 minutes and no shipping to a lab

Published:
November 25, 2020
Coverage:
Digital Transformation More...
Activities:
Product
by Danielle Bradnan
Very important

This advancement in POC testing is one that decentralizes the testing process and allows for nearly immediate self-quarantine and thereby reducing the burden on shipping and laboratory infrastructure. While clients may want to take note of this development for use for their own employees, clients looking at the home testing space should see this as a signpost. Consumers being exposed to the convenience of at-home testing will continue to have an appetite for it, and opportunities for home testing for common conditions like the flu and strep throat remain to be tapped. Incorporating rapid testing into a telehealth model is an increasingly viable approach to capturing revenue while bringing value to patients.

For the original news article, click here .


Further Reading

Identifying viruses from exhaled breath is promising but may not be available before end of COVID-19 pandemic

News Commentary | October 30, 2020

Imec has started developing a new COVID‑19 testing tool that can identify COVID‑19 virus particles in patients' exhaled breath. The new method, if it works, will allow faster and more comfortable testing than the incumbent PCR and antigen tests involving nose swabbing and blood draws. Imec aims to ... Not part of subscription

Diagnosing cancers using electronic noses, while getting closer, still faces challenges

News Commentary | June 11, 2021

Researchers from the University of Pennsylvania demonstrated using electronic noses to diagnose cancers that are usually difficult to detect. The e‑noses leverage gas sensor arrays and AI to analyze the pattern of volatile organic compounds emitted from blood samples. The results are based on ... Not part of subscription

Helix's pivot from consumer genomics to population genomics highlights broader shifts in the human genomics landscape

Case Study | July 29, 2021

Helix Genomics came into the spotlight a few years ago when it pioneered a digital marketplace concept for genomics where it used a dynamic consent model to allow third‑party developers to turn genomics data into personalized insights for the consumer. It also offered whole‑exome sequencing (WES), ... Not part of subscription